Skip to main content

Sheridan John F's Form 4 filing

Tandem Diabetes Care Inc (TNDM) · filed Aug 18, 2026

Accession no.
0001438133-26-000131
Filed
Aug 18, 2026, 4:28 PM ET
Trade date
Aug 15, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sheridan John FCIK 0001365369Director, Officer (PRESIDENT & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 15, 2026Common StockMOption exerciseAcquired+5,982$0.00$0158,425Direct
Aug 15, 2026Common StockFTax withholdingDisposed−3,044$22.72−$69,159.68155,381Direct
Aug 15, 2026Common StockMOption exerciseAcquired+9,934$0.00$0165,315Direct
Aug 15, 2026Common StockFTax withholdingDisposed−5,055$22.72−$114,849.6160,260Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 15, 2026Common StockMOption exerciseDisposed−5,982$0.00$017,947Direct
Aug 15, 2026Common StockMOption exerciseDisposed−9,934$0.00$069,537Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)